SEC Form 5 · accession 0001179110-18-002002
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Xiaodong Wang
Director
Period of report
Dec 31, 2017
Accepted (ET)
Feb 13, 2018 · 4:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1,F2 | Dec 22, 2017 | G | 36,400 | $0.00 | D | 12,879,311 | D | |
| Ordinary SharesF2,F3 | holding | — | — | — | 224,372 | I | See Footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Bona fide gift of shares which is exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5.
- F2The total reported in Column 5 has been adjusted to correct an error in the total holding reflected in a Form 4 filed on June 30, 2017 and the subsequent Form 4s.
- F3These securities are held in a UTMA account for the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.